| RS149200446 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCC2-related disorder, ABCC2-related disorder |
| RS149200800 |
SLC9A7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149201271 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS149201273 |
NDUFS8
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS149201802 |
RAD50
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS149202369 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS149202766 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS149202847 |
IL27RA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149202905 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9 |
| RS149203102 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Ehlers-Danlos syndrome |
| RS149203108 |
FOXI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 4, FOXI1-related disorder |
| RS149203278 |
NALCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149204722 |
LAMB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMB1-related disorder |
| RS149208294 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS149209011 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly |
| RS149209714 |
ALG12
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG12-congenital disorder of glycosylation, ALG12-related disorder |
| RS149210297 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD1-related disorder, Polycystic kidney disease |
| RS149210307 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, AGL-related disorder |
| RS149210630 |
ELAC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS149212045 |
ARHGEF7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149212775 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS149213151 |
ARHGEF17
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149213379 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS149215094 |
VAPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 8 |
| RS149215868 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS149216103 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS149216939 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Inborn genetic diseases |
| RS149217423 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS149218670 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS149222287 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149222396 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS149223439 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS149224363 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Andersen Tawil syndrome, Atrial fibrillation |
| RS149224639 |
APOO
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149224679 |
FASN
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS149225252 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS149225624 |
TRAPPC14
|
Health Risk |
Pathogenic |
Microcephaly 25, primary |
| RS149226993 |
XPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS149227065 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS149227308 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS149227847 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS149228565 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS149228705 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS149229231 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS149232277 |
ZNF335
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149232501 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS149232991 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS149233109 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS149233888 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
RTTN-related disorder, RTTN-related disorder |
| RS149234202 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS149236286 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS149237353 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperthyroidism due to mutations in TSH receptor, Familial gestational hyperthyroidism |
| RS149237647 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS149237737 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS149238501 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS149239881 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Mucopolysaccharidosis |
| RS149239987 |
NEK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 9, Nephronophthisis 9 |
| RS149240122 |
TMEM237
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 14, Joubert syndrome 14 |
| RS149240770 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2 |
| RS149241435 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS149241739 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS149243712 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS149243979 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, Congenital ichthyosis of skin |
| RS149244124 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS149244653 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS149244943 |
PHKB
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXb, Glycogen phosphorylase kinase deficiency |
| RS149246093 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation syndrome, Cardiovascular phenotype |
| RS149248727 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS149248784 |
COG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type IIq |
| RS149249176 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS149249195 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Inborn genetic diseases |
| RS149249456 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS149250142 |
CIT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149251662 |
SPG21
|
Health Risk |
Conflicting classifications of pathogenicity |
Mast syndrome, Hereditary spastic paraplegia |
| RS149252070 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Hirschsprung disease |
| RS149252796 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |
| RS149253719 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early repolarization associated with ventricular fibrillation, Cardiovascular phenotype |
| RS149254654 |
ERLIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS149255362 |
ROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS149255516 |
MST1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149255570 |
KCTD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 3, Inborn genetic diseases |
| RS149256584 |
DNM1L
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS149257266 |
TNK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149258390 |
MSRB3
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 74, Autosomal recessive nonsyndromic hearing loss 74 |
| RS149258462 |
IL2RB
|
Health Risk |
Conflicting classifications of pathogenicity |
IL2RB-related disorder, IL2RB-related disorder |
| RS149259672 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS149259791 |
PDZD4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149260051 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS149260479 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1 |
| RS149261556 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS149261557 |
GPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Wilms tumor 1 |
| RS149262370 |
BARD1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS149262877 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS149263390 |
AP3B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 2, AP3B1-related disorder |
| RS149264109 |
EPRS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149264256 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, EIF2B5-related disorder |
| RS149264703 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Inborn genetic diseases |
| RS149264761 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149265978 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS149266076 |
RFT1
|
Health Risk |
Conflicting classifications of pathogenicity |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |